阿尔茨海默病诊断标准:从临床诊断到病理生理诊断
Evolution of diagnostic criteria for Alzheimers disease: from clinical diagnosis to pathophysiological diagnosis

DOI: 10.6040/j.issn.1671-7554.0.2017.320

Keywords: 阿尔茨海默病,诊断标准,生物标记物,AD临床前阶段,
Alzheimers disease,Diagnostic criteria,Biomarker,Preclinical AD

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimers disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimers Disease[J]. Neurology, 1984, 34(7): 939-944.
[2]	Morris JC, Blennow K, Froelich L, et al. Harmonized diagnostic criteria for Alzheimers disease: recommendations[J]. J Intern Med, 2014, 275(3): 204-213.
[3]	Baldereschi M, Amato MP, Nencini P, et al. Cross-national interrater agreement on the clinical diagnostic criteria for dementia. WHO-PRA Age-Associated Dementia Working Group, WHO-Program for Research on Aging, Health of Elderly Program[J]. Neurology, 1994, 44(2): 239-242.
[4]	Morris JC. Early-stage and preclinical Alzheimer disease[J]. Alzheimer Dis Assoc Disord, 2005, 19(3): 163-165.
[5]	Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimers disease: recommendations from the National Institute on Aging-Alzheimers Association Workgroups on diagnostic guidelines for Alzheimers disease[J]. Alzheimers Dement, 2011, 7(3): 280-292.
[6]	Perret-Liaudet A, Pelpel M, Tholance Y, et al. Risk of Alzheimers disease biological misdiagnosis linked to cerebrospinal collection tubes[J]. J Alzheimers Dis, 2012, 31(1): 13-20.
[7]	Harris JM, Thompson JC, Gall C, et al. Do NIA-AA criteria distinguish Alzheimers disease from frontotemporal dementia?[J]. Alzheimers Dement, 2015, 11(2): 207-215.
[8]	Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria[J]. Lancet Neuro, 2007, 6(8): 734-746.
[9]	Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimers disease: recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimers disease[J]. Alzheimers Dement, 2011, 7(3): 280-292.
[10]	Graham JE, Rockwood K, Beattie BL, et al. Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging[J]. Neuroepidemiology, 1996, 15(5): 246-256.
[11]	Fratiglioni L, Grut M, Forsell Y, et al. Clinical diagnosis of Alzheimers disease and other dementias in a population survey. Agreement and causes of disagreement in applying Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition, Criteria[J]. Arch Neurol, 1992, 49(9): 927-932.
[12]	Varma AR, Snowden JS, Lloyd JJ, et al. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimers disease and frontotemporal dementia[J]. J Neurol Neurosurg Psychiatry, 1999, 66(2): 184-188.
[13]	Kazee AM, Eskin TA, Lapham LW, et al. Clinicopathologic correlates in Alzheimer disease: assessment of clinical and pathologic diagnostic criteria[J]. Alzheimer Dis Assoc Disord, 1993, 7(3): 152-164.
[14]	de Jager CA, Honey TE, Birks J, et al. Retrospective evaluation of revised criteria for the diagnosis of Alzheimers disease using a cohort with post-mortem diagnosis[J]. Int J Geriatr Psychiatry, 2010, 25(10): 988-997.
[15]	Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on mild cognitive impairment[J]. J Intern Med, 2004, 256(3): 240-246.
[16]	王晓妮, 唐毅, 韩璎.阿尔茨海默病诊断标准的演变[J].医学研究生学报, 2015, 28(2): 195-198. WANG Xiaoni, TANG Yi, HAN Ying. The evolution of criteria for the diagnosis of Alzheimers disease[J].J Med Postgra, 2015, 28(2): 195-198.
[17]	Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimers disease: the IWG-2 criteria[J]. Lancet Neuro, 2014, 13(6): 614-629.
[18]	Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimers disease: recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimers disease[J]. Alzheimers Dement, 2011, 7(3): 270-279.
[19]	McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimers disease: recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimers disease[J]. Alzheimers Dement, 2011, 7(3): 263-269.
[20]	Hjortso S, Butler B, Clemmesen L, et al. The use of case vignettes in studies of interrater reliability of psychiatric target syndromes and diagnoses. A comparison of ICD-8, ICD-10 and DSM-III[J]. Acta Psychiatr Scand, 1989, 80(6): 632-638.
[21]	Larson EB, McCurry SM, Graves AB, et al. Standardization of the clinical diagnosis of the dementia syndrome and its subtypes in a cross-national study: the Ni-Hon-Sea experience[J]. J Gerontol A Biol Sci Med Sci, 1998, 53(4): M313-319.
[22]	Lim A, Tsuang D, Kukull W, et al. Clinico-neuropathological correlation of Alzheimers disease in a community-based case series[J]. J Am Geriatr Soc, 1999, 47(5): 564-569.
[23]	Ranginwala NA, Hynan LS, Weiner MF, et al. Clinical criteria for the diagnosis of Alzheimer disease: still good after all these years[J]. Am J Geriatr Psychiatry, 2008, 16(5): 384-388.
[24]	Slaets S, Le Bastard N, Theuns J, et al. Amyloid pathology influences abeta1-42 cerebrospinal fluid levels in dementia with lewy bodies[J]. J Alzheimers Dis, 2013, 35(1): 137-146.
[25]	Bian H, Van Swieten JC, Leight S, et al. CSF biomarkers in frontotemporal lobar degeneration with known pathology[J]. Neurology, 2008, 70(19 Pt 2): 1827-1835.
[26]	Schoonenboom NS, Reesink FE, Verwey NA, et al. Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort[J]. Neurology, 2012, 78(1): 47-54.
[27]	de Souza LC, Lamari F, Belliard S, et al. Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimers disease from other cortical dementias[J]. J Neurol Neurosurg Psychiatry, 2011, 82(3): 240-246.
[28]	Brys M, Pirraglia E, Rich K, et al. Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment[J]. Neurobiol Aging, 2009, 30(5): 682-690.
[29]	Visser PJ, Vos S, van Rossum I, et al. Comparison of International Working Group criteria and National Institute on Aging-Alzheimers Association criteria for Alzheimers disease[J]. Alzheimers Dement, 2012, 8(6): 560-563.
[30]	Dubois B, Feldman HH, Jacova C, et al. Revising the definition of Alzheimers disease: a new lexicon[J]. Lancet Neuro, 2010, 9(11): 1118-1127.
[31]	Aizenstein HJ, Nebes RD, Saxton JA, et al. Frequent amyloid deposition without significant cognitive impairment among the elderly[J]. Arch Neurol, 2008, 65(11): 1509-1517.
[32]	Price JL, Morris JC. Tangles and plaques in nondemented aging and “preclinical” Alzheimers disease[J]. Ann Neurol, 1999, 45(3): 358-368.
[33]	Bennett DA, Schneider JA, Arvanitakis Z, et al. Neuropathology of older persons without cognitive impairment from two community-based studies[J]. Neurology, 2006, 66(12): 1837-1844.

Full-Text